Literature DB >> 8929722

Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.

A K Kalloghlian1, H H Frayha, M M deMoor.   

Abstract

UNLABELLED: We describe a newborn with cyanotic congenital heart disease who developed severe cortical hyperostosis of his long bones simulating osteomyelitis with remarkable elevation of alkaline phosphatase on the 11th day of prostaglandin E1 (PGE1) infusion. Soft tissue swelling and tenderness disappeared 6 days after discontinuation of PGE1, however alkaline phosphatase remained high.
CONCLUSION: To our knowledge this is the first reported case that presented with such an acute complication of PGE1 therapy within a short period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929722     DOI: 10.1007/bf01953932

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Plain film and CT observations in prostaglandin-induced bone changes.

Authors:  M A Matzinger; V A Briggs; H J Dunlap; K Udjus; D J Martin; P McDonald
Journal:  Pediatr Radiol       Date:  1992

2.  Gastric-outlet obstruction induced by prostaglandin therapy in neonates.

Authors:  N Peled; O Dagan; P Babyn; M M Silver; G Barker; J Hellmann; D Scolnik; G Koren
Journal:  N Engl J Med       Date:  1992-08-20       Impact factor: 91.245

3.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

4.  Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.

Authors:  M D Freed; M A Heymann; A B Lewis; S L Roehl; R C Kensey
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

5.  Pharmacologic use of prostaglandin E1 in infant with congenital heart disease.

Authors:  M A Heymann
Journal:  Am Heart J       Date:  1981-06       Impact factor: 4.749

6.  Soft-tissue swelling in two neonates during prostaglandin E1 therapy.

Authors:  S Jureidini; N A Chase; B S Alpert; T Vanderzalm; R E Sheneflet
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

7.  Case report 701: Prostaglandin E1 (PGE1) periostitis.

Authors:  R F Rowley; J P Lawson
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

8.  Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.

Authors:  A B Lewis; M D Freed; M A Heymann; S L Roehl; R C Kensey
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

9.  Bone changes from prostaglandin therapy.

Authors:  A K Poznanski; S K Fernbach; T E Berry
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

10.  Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation.

Authors:  K Woo; J Emery; J Peabody
Journal:  Pediatrics       Date:  1994-03       Impact factor: 7.124

  10 in total
  2 in total

Review 1.  PROSTAGLANDINS IN CONGENITAL HEART DISEASE.

Authors:  M Sharma; M Sasikumar; S D Karloopia; B N Shahi
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.

Authors:  Smita Akkinapally; Shilpa G Hundalani; Madhulika Kulkarni; Caraciolo J Fernandes; Antonio G Cabrera; Binoy Shivanna; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2018-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.